Olema Pharmaceuticals, Inc. (OLMA)

27.14 -2.05 (-7.02%) USD  |  NASDAQ  |  Jan 16, 16:00
25.64 -1.50 (-5.53%) After-Hours: 07:36
More

Olema Pharmaceuticals Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for OLMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade
Cogent Biosciences, Inc. Upgrade
Replimune Group, Inc. Upgrade
Genprex, Inc. Upgrade

Total Expenses (Quarterly) Related Metrics

Net Income (Quarterly) Upgrade
EPS Diluted (Quarterly) Upgrade
Enterprise Value Upgrade
Earnings Yield Upgrade
Normalized Earnings Yield Upgrade